Bone mineral density in patients with metastatic prostate cancer with or without androgen deprivation therapy
APMC-Annals of Punjab Medical College. 2011; 5 (1): 7-14
em Inglês
| IMEMR
| ID: emr-175237
ABSTRACT
Prostate cancer commonly metastatize to skeletal sites. Androgen deprivation therapy [ADT], the primary treatment of metastatic prostate cancer, may result in osteoporosis. Bone mineral density evaluation during androgen deprivation therapy can detect patients at risk of osteoporotic fractures
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Idioma:
Inglês
Revista:
Ann. Punjab Med. Coll.
Ano de publicação:
2011
Similares
MEDLINE
...
LILACS
LIS